“Because the cause of stroke in young people can be hard to identify, cholesterol-lowering drugs are often not used to prevent further strokes or vascular problems,” said study author Jukka Putaala, MD, PhD, with the Helsinki University Central Hospital in Helsinki, Finland. “This study suggests that the drugs should be considered even when the cause of the stroke is unknown and the cholesterol levels are not high.”
For the study, researchers looked at the medical records of 215 people between the ages of 15 and 49 who experienced a first stroke called an ischemic stroke and were then followed for an average of nine years.
One-third of the participants had taken a statin at some point after their stroke. Of the 36 people who continuously took a statin, no one had a second stroke or other vascular problem. Of the 36 people who took a statin at some point after their stroke, four people, or 11 percent, had a second stroke or other vascular problem. Of the 143 people who never took a statin drug, 29 people, or 20 percent, had a second stroke or other vascular problem.
The study found that those who were treated with a statin at any time after the stroke were 77 percent less likely to experience another stroke or vascular problems compared to those not treated with a statin at all. The results were the same after adjusting for factors such as age, high blood pressure, and taking high blood pressure medication.
“While the study may be limited by the small number of people who were treated with a statin, at the very least, young adults who have experienced a stroke for unknown reasons should be considered for treatment with cholesterol-lowering drugs,” said Putaala.
The study was supported by the Helsinki University Central Hospital, the Finnish Medical Foundation, the Finnish Brain Foundation and the Emil Aaltonen Foundation.
The American Academy of Neurology, an association of more than 24,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson’s disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com.
Leah C. Reilly | American Academy of Neurology
The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung
A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Life Sciences
20.01.2017 | Physics and Astronomy
20.01.2017 | Materials Sciences